Researchers have achieved a significant milestone in HIV prevention with a novel vaccine combination that reduces the risk of contracting HIV by 31%.
This approach merges two existing vaccines, which showed limited effectiveness on their own. Combined, they deliver substantial protection, as demonstrated in a rigorous clinical trial.
The study, led by the U.S. military in partnership with Thailand's Ministry of Health, enrolled over 16,000 volunteers aged 18-30 across Thailand.
